DHA extends its thankfulness and appreciation for the relentless cooperation and support provided by its strategic partners in health sector; in an effort to provide integrated health care system and improve the levels and quality of services provided in Emirate of Dubai.

Based on jurisdiction and scope of Dubai Health Authority, and in line with the precautionary and preventive measures taken by UAE in general and Dubai

in particular, and based on DHA earlier circular dated 01/11/2021 regarding Updated Guidance on Eligibility for MRNA COVID-19 (BNT162b2) Vaccine (Version 7.0) (Ref: DHA/OUT/2021/0003960), thus we announce the issuance of the updated  Pfizer Eligibility Guidelines (Version 7.1) which have been developed in coordination and cooperation with COVID-19 Command and Control Center as attached.

This circular and the attached standards & guidelines are effective from the date of its issuance Accordingly, all health professionals and health facilities within the jurisdiction of DHA must familiarize with the aforementioned  standards &  guidelines attached to this circular and strictly adhere to the provisions contained therein in order to avoid any legal accountability.

For more information, kindly contact the call centre on:

Telephone: 800-342

Email address: regulation@dha.gov.ae